Journal
NATURE CELL BIOLOGY
Volume 11, Issue 2, Pages 204-U196Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ncb1828
Keywords
-
Categories
Funding
- National Institutes of Health (NIH)
- Richard Schulze Family Foundation
- Susan G. Komen Breast Cancer Foundation
- NIH [CA130996]
- Department of Defense,
- Mayo Clinic Breast SPORE
Ask authors/readers for more resources
Topoisomerase II (Topo II) is required to separate intertwined sister chromatids before chromosome segregation can occur in mitosis(1). However, it remains to be resolved whether Topo II has any role in checkpoint control. Here we report that when phosphorylated, Ser 1524 of Topo II alpha acts as a binding site for the BRCT domain of MDC1 (mediator of DNA damage checkpoint protein-1), thereby recruiting MDC1 to chromatin. Although Topo II alpha-MDC1 interaction is not required for checkpoint activation induced by DNA damage, it is required for activation of the decatenation checkpoint. Mutation of Ser 1524 results in a defective decatenation checkpoint. These results reveal an important role of Topo II in checkpoint activation and in the maintenance of genomic stability.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available